Ferma.AI - A product of ZoomRx

ASH 2022 will feature innovative methods for treating Diffuse Large B-cell Lymphoma (DLBCL)

As the healthcare industry continues to comb through ASH abstracts for crucial insights before the 2022 annual conference, we at ZoomRx have used Ferma.AI, ZoomRx's comprehensive medical congress intelligence platform, to assemble crucial information in the healthcare market. Important information on the Diffuse Large B-cell Lymphoma (DLBCL) market at

ASH22: Showcasing cutting-edge approaches for treating Acute Myeloid Leukemia (AML)

Abstracts for the American Society of Hematology’s (ASH) 64th Annual Meeting were released on November 3rd, in anticipation of opening remarks beginning in New Orleans on December 10. As the healthcare world begins to pore over the abstracts for key insights, we used Ferma.AI, ZoomRx’s comprehensive scientific

Physicians aren't quitting Twitter over Elon Musk!

Physicians aren't quitting Twitter over Elon Musk!

It’s been a chaotic month for Elon Musk and his recent acquisition, Twitter. Musk's tenure at the company so far has been mired in controversy as the mercurial billionaire makes changes to the platform and cuts staff, and a number of high-profile users have already jumped ship. However, amidst

HER2-Negative Breast Cancer Intelligence: Oct'22

SUBMIT Thanks for your interest. We have received your information and member of our team will be in touch with you shortly.

HER2-negative Breast Cancer Intelligence: Oct'22 Week 2

SUBMIT Thanks for your interest. We have received your information and member of our team will be in touch with you shortly.

HER2-negative Breast Cancer Intelligence: Oct'22 Week 1

SUBMIT Thanks for your interest. We have received your information and member of our team will be in touch with you shortly.

Recent Advances in Multiple Myeloma (ASH 2021)

Recent Advances in Multiple Myeloma (ASH 2021)

Data that was released during the American Society of Hematology (ASH) 2021 meeting represents significant progress in the field and will have a positive impact on patients’ lives. Below are a few of the key trials generating excitement and representing advances in the treatment of multiple myeloma (MM). [FERMA.AI

Evolving Congress Competitive Intelligence With Artificial Intelligence

The following is the abstract for an upcoming poster presentation at the International Society of Medical Publication Professionals' 17th annual meeting to be held April 12-14, 2021. Authors: Jennifer Ghitha, Cheryl Truchana, Zena Askerovaa, Dheepa Charia, Raj Patela and Vivekanandan Mathivananb aPfizer Inc., New York, NY, USA, bFerma AI, ZoomRx

Developing a new playbook for covering virtual conferences

Developing a new playbook for covering virtual conferences

Since March, over 500 medical conferences have moved to a fully-virtual format. Given the current state of the pandemic and the CDC’s guidelines for event organizers, it is likely that virtual conferences will continue to be the standard for the foreseeable future. In order to make the most out

Virtual Conferences and the Challenge of Physician Engagement

Virtual Conferences and the Challenge of Physician Engagement

Since March, over 500 medical conferences have moved to a fully-virtual format. Given the current state of the pandemic and the CDC’s guidelines for event organizers, it is likely that virtual conferences will continue to be the standard for the foreseeable future. In order to take full advantage of

AACR in 6,000 Tweets: Measuring Digital Reaction to this Year's Virtual Meeting

AACR in 6,000 Tweets: Measuring Digital Reaction to this Year's Virtual Meeting

This year’s American Association for Cancer Research meeting was held virtually in order to continue the dissemination of key clinical and scientific information, despite the ongoing pandemic. From an attendance perspective the meeting was a massive success, drawing a reported 61,000 registrants (up from a typical attendance of

Conferences Going Virtual

The ongoing COVID-19 pandemic is presenting unforeseen challenges to the industry as major medical conferences are being forced to cancel in-person events and go digital. At Ferma.AI, we want to be as helpful as possible for you and your team and have compiled the below tracker. Full list of

AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis

AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis

As of March 13, the AAN annual meeting has been cancelled due to the ongoing global COVID-19 (Coronavirus) pandemic. We'll be keeping a close eye on any plans to hold events digitally and adapting our coverage plans accordingly. Scientific abstracts for the American Academy of Neurology annual meeting (April 25th